-

Epilepsy Therapeutics Market Report 2025-2030 with Analyst Recommendations - Focus on Innovation in Drug Formulation, & Telemedicine and Digital Health - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Epilepsy Therapeutics Market With Impact Analysis of US Tariffs (2025 Edition)" report has been added to ResearchAndMarkets.com's offering.

The Global Epilepsy Therapeutics market showcased growth at a CAGR of 3.97% during 2020-2023. The market was valued at USD 11.48 billion in 2023 which is expected to reach USD 15.81 billion in 2030.

The epilepsy therapeutics market is projected to experience sustained growth over the coming years, driven by increasing epilepsy prevalence, rising awareness, advancements in drug development, and greater access to healthcare across both developed and emerging markets.

Increasing diagnosis rates, greater awareness, and improved access to healthcare are contributing to rising epilepsy prevalence worldwide. Aging populations and the higher incidence of epilepsy in both the very young and elderly are further driving demand for effective therapeutics.

The global burden of epilepsy, affecting over 50 million people, continues to drive demand. Regions with increasing awareness and healthcare access, such as Latin America, are particularly contributing to growth as epilepsy is highly prevalent, especially in children.

High demand for paediatric epilepsy care has been observed due to rising incidence rates and population growth. There is a focus on making Anti-Epileptic Drugs more accessible in this region as awareness and diagnosis rates improve.

Competitive Positioning

  • Companies' Product Positioning
  • Market Position Matrix
  • Market Share Analysis of Epilepsy Therapeutics Market

Company Profiles

  • Novartis
  • Pfizer
  • GSK plc.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Sanofi
  • Teva Pharmaceuticals
  • Abbott Laboratories
  • Jazz Pharmaceuticals
  • Neurelis, Inc.

Key Topics Covered:

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology

2. Analyst Recommendations

2.1 Innovation in Drug Formulation

2.2 Telemedicine and Digital Health

3. Epilepsy Therapeutics Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Epilepsy Therapeutics Market

3.2 Global Prevalence of Infectious Disease, 2019

3.3 Global Incidence of Infectious Disease, 2019

3.4 Major Epilepsy Drugs in Pipeline, 2024

3.5 Global Epilepsy Therapeutics Market: Dashboard

3.6 Global Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

3.7 Global Epilepsy Therapeutics Market: Market Value Assessment

3.8 Global Epilepsy Therapeutics Market Segmentation: By Generation

3.8.1 Global Epilepsy Therapeutics Market, By Generation Overview

3.8.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Generation

3.8.3 Global Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR)

3.8.4 Global Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR)

3.8.5 Global Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR)

3.9 Global Epilepsy Therapeutics Market Segmentation: By Route of Administration

3.9.1 Global Epilepsy Therapeutics Market, By Route of Administration Overview

3.9.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Route of Administration

3.9.3 Global Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)

3.9.4 Global Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)

3.10 Global Epilepsy Therapeutics Market Segmentation: By Type

3.10.1 Global Epilepsy Therapeutics Market, By Type Overview

3.10.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Type

3.10.3 Global Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR)

3.10.4 Global Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR)

4. Epilepsy Therapeutics Market, Region Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot

For more information about this report visit https://www.researchandmarkets.com/r/saa36n

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

Disulfiram Market Report 2025-2032: Growth Forecast, Segment Shares, FPNV Positioning Matrix and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Disulfiram Market is advancing in scope and strategic significance as evolving clinical practices, regulatory shifts, and technology continue to reframe substance use disorder management. Senior executives must navigate opportunities and risks shaped by global healthcare transformation, positioning their organizations for competitive relevance. Market Snap...

Instant Hot Pot Self-Heating Rice Market Analysis 2025-2032: Emerging Trends, Market Share Analysis, FPNV Positioning Matrix - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Instant Hot Pot Self-Heating Rice Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The instant hot pot self-heating rice market is evolving rapidly, as global consumers increasingly seek convenient meal solutions that deliver authentic taste and consistent quality. Advancements in self-heating technology and dynamic shifts in consumer lifestyles are driving substantial growth across multiple regions and segments. Marke...
Back to Newsroom